The evolving role of Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia

by Max J. Gordon, Alexey V. Danilov
Published 2021-01-01

Refractory Autoimmune Cytopenias Treated With Venetoclax

by Max J. Gordon, Edward Maldonado, Alexey V. Danilov
Published 2019-06-01

Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Passé Yet?

by Alexey V. Danilov, John M. Pagel, Jennifer R. Brown, Brian T. Hill
Published 2019-08-01

Correction: DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance.

by Alexey V Danilov, Divas Neupane, Archana Sidalaghatta Nagaraja, Elena V Feofanova, Leigh Ann Humphries, James DiRenzo, Murray Korc
Published 2018-01-01

DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance.

by Alexey V Danilov, Divas Neupane, Archana Sidalaghatta Nagaraja, Elena V Feofanova, Leigh Ann Humphries, James DiRenzo, Murray Korc
Published 2011-01-01

Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells.

by Cody Paiva, J Claire Godbersen, Ryan S Soderquist, Taylor Rowland, Sumner Kilmarx, Stephen E Spurgeon, Jennifer R Brown, Sreesha P Srinivasa, Alexey V Danilov
Published 2015-01-01